M4I Division of Imaging Mass Spectrometry
Developing and applying state-of-the-art mass spectrometry based molecular imaging approaches for nanomedicine and biomedical research, including mass spectrometry as a diagnostic and prognostic tool for personalized medicine in oncology, neurology and cardiovascular medicine.
- biomedical cellular and tissue research
- division of Imaging Mass Spectrometry, led by Prof. Ron M.A. Heeren
- translates molecular insights into clinical solutions
- works towards the molecular operating room
- focuses on Collaborative Open Research Education (CORE)
IMS CORE lab teams up with Cristal TherapeuticsMonday, July 6, 2020
The ICARUS project will be carried out in close collaboration with the IMS CORE lab at the M4I division of Imaging Mass Spectrometry, where CriPec® nanoparticle microlocalisation and drug release in tumours will be evaluated.
How the coronavirus infects our small intestinesMonday, May 18, 2020
Interview with prof. Peter Peters on the Science article he co-worked on intensively.
Coronavirus SARS-CoV-2 infects cells of the intestineFriday, May 1, 2020
Researchers from the Hubrecht Institute in Utrecht, Erasmus MC University Medical Center Rotterdam, and Maastricht University in the Netherlands have found that the coronavirus SARS-CoV-2, which causes COVID-19, can infect cells of the intestine and multiply there.
The M4I Division of Imaging Mass Spectrometry is one of the world leaders in high resolution molecular imaging of biological surfaces. The division targets the development and application of state-of-the-art mass spectrometry based molecular imaging approaches for biomedical cellular and tissue research. Main research aim for the coming years is to develop and apply mass spectrometry as a diagnostic and prognostic tool for personalized medicine.
The New Dawn of Cancer Surgery |
Ron Heeren | TEDxMaastricht Nov 3, 2016
Pioneer prof. dr. Ron Heeren, University professor at Maastricht University and key player in the Top Research Institute M4I (Maastricht MultiModal Molecular Imaging Institute) is at the forefront of technological breakthroughs in oncology, neurology and cardiovascular medicine. Heeren’s team is developing biomedical applications of Mass Spectroscopy Imaging (MSI), or in other words techniques to photograph molecules.